Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000814133-25-000117·C4 Therapeutics, Inc.
Schedule 13G ownership disclosure
C4 Therapeutics Inc
COM STK · CUSIP: 12529R107
Event date: 2025-09-30
- Filing-level shares
- 4,852,741.00
- Percent of class
- 6.8%
- Wasatch Advisors LP
Shares: 4,852,741.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000814133-25-000117
- Form type
- SCHEDULE 13G/A
- Filer
- C4 Therapeutics, Inc.
- CIK
- CIK 1662579
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership